
8MM respiratory syncytial virus prevention market to reach $6.2b by 2030
Thanks to the introduction of new monoclonal antibodies and vaccines. According to GlobalData, the respiratory syncytial virus (RSV) prevention market across eight major markets (8MM) is expected to reach US$620 million by